MET EXON 14 MUTATION

Clinical trials for MET EXON 14 MUTATION explained in plain language.

Never miss a new study

Get alerted when new MET EXON 14 MUTATION trials appear

Sign up with your email to follow new studies for MET EXON 14 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New drug combo aims to shrink lung tumors before surgery in targeted trial

Disease control Not yet recruiting

This study tests whether a drug called bozitinib, combined with chemotherapy, can shrink tumors in people with a specific genetic lung cancer (MET-altered) before they have surgery. About 34 adults with stage IIA to IIIC non-small cell lung cancer will receive the treatment and t…

Matched conditions: MET EXON 14 MUTATION

Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control

Last updated May 17, 2026 09:09 UTC

MET EXON 14 MUTATION

Get alerted when new MET EXON 14 MUTATION trials appear

New drug combo aims to shrink lung tumors before surgery in targeted trial